Insulin-induced localized lipoatrophy preceded by shingles (herpes zoster): A case report

被引:4
作者
Chantelau E.A. [1 ]
Prätor R. [2 ]
Prätor J. [2 ]
机构
[1] 40223 Düsseldorf
[2] 48431 Rheine
关键词
Herpes Zoster; Insulin Lispro; Continuous Subcutaneous Insulin Infusion; Insulin Pump; Humalog;
D O I
10.1186/1752-1947-8-223
中图分类号
学科分类号
摘要
Introduction. Localized involutional lipoatrophy of subcutaneous adipose tissue may develop due to subcutaneous injection of pharmaceutical preparations. The pathogenesis of this adverse drug reaction is unknown. The progression of localized involutional lipoatrophy ceases and occasionally it resolves after withdrawing the inducing agent. In case of localized involutional lipoatrophy due to subcutaneous insulin therapy, low-dose systemic corticosteroids may be curative despite ongoing insulin administration. Case presentation. We report a recurrence of insulin-induced localized involutional lipoatrophy at the abdominal wall in a 57-year-old Caucasian woman with type-1 diabetes on continuous subcutaneous insulin infusion. The first episode of insulin-induced localized involutional lipoatrophy two years previously had been cured by oral prednisone. The recurrence was treated immediately with 10mg prednisone once daily for five months, and was cured thereafter. The insulin analog preparation (Humalog™) and the insulin pump equipment (Accu-Chek Spirit™) applied were the same during both episodes. Both episodes were preceded by a temporary disturbance of the immune balance (the first episode by vaccination, the second episode through shingles). Conclusions: This case confirms that insulin-induced localized involutional lipoatrophy in type-1 diabetes can occur again, and can be cured by systemic corticosteroids. We suggest that temporary disturbance of the immune balance may trigger this transitory idiosyncratic reaction in a susceptible individual. © 2014 Chantelau et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 22 条
[1]  
Lopez X., Castells M., Ricker A., Velazquez E.F., Mun E., Goldfine A.B., Human insulin analog-induced lipoatrophy, Diabetes Care, 31, pp. 443-444, (2008)
[2]  
Cabrera-Freitag P., Escalada J., Goikoetxea M.J., Laguna S., Sanz M.L., Gastaminza G., A severe case of lipoatrophy due to human insulin and insulin analogs in a patient with diabetes: Is an immunological mechanism involved?, J Investig Allergol Clin Immunol, 21, pp. 417-419, (2011)
[3]  
Aviles-Izquierdo J.A., Longo-Imedio M.I., Hernanz-Hermosa J.M., Lazaro-Ochaita P., Bilateral localized lipoatrophy secondary to a single intramuscular corticosteroid injection, Dermatol Online J, 12, (2006)
[4]  
Peteiro-Gonzalez D., Fernandez-Rodriguez B., Cabezas-Agricola J.M., Araujo-Vilar D., Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus, Diabetes Res Clin Pract, 91, (2011)
[5]  
Chantelau E.A., Prator R., Prator J., Poll L.W., Relapsing insulin-induced lipoatrophy, cured by prolonged low-dose oral prednisone: A case report, Diabetol Metab Syndr, 3, (2011)
[6]  
Milan G., Murano I., Costa S., Pianta A., Tiengo C., Zulato E., Centobene C., Bruttomesso D., Cinti S., Vettor R., Lipoatrophy induced by subcutaneous insulin infusion. Ultrastructural analysis and gene expressing profiling, J Clin Endocrinol Metab, 95, pp. 3126-3132, (2010)
[7]  
Nagase T., Katsura Y., Iwaki Y., Nemoto K., Sekine H., Miwa K., Oh-I T., Kou K., Iwaya K., Noritake M., Matsuoka T., The insulin ball, Lancet, 373, (2009)
[8]  
Babiker A., Datta V., Lipoatrophy with insulin analogues in type 1 diabetes, Arch Dis Child, 96, pp. 101-102, (2011)
[9]  
Touraine P., D'Souza G.A., Kourides I., Abs R., Barclay P., Xie R., Pico A., Torres-Vela E., Ekman B., Lipoatrophy Study Group G.H., Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH, Eur J Endocrinol, 161, pp. 533-540, (2009)
[10]  
Tavare A.N., Doolittle H.J., Baburaj R., Case report. Pan-insulin allergy and severe lipoatrophy complicating type-2 diabetes, Diabet Med, 28, pp. 500-503, (2011)